头文字d

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

一 |     　　兰州8月26日电 (记者 冯志军)兰州海关26日发布消息称，由兰州海关技术中心牵头制定的苦水玫瑰精油国家标准发布，填补了国内苦水玫瑰精油行业标准的空白，也为甘肃苦水玫瑰产业走出“优质不优价”的困局打开了突破口。

二 |     (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。

三 | 　　“以前没有统一的质量标准，产品品质参差不齐，好精油卖不上好价钱。现在国家标准出来了，我们按标生产、凭标定价，市场认了，销路也宽了。”甘肃大手印玫瑰科技有限公司总经理把存礼说。8月下旬，兰州海关技术中心工作人员开展苦水玫瑰香气成分检测分析。

四 | 冯茜 摄　　苦水玫瑰是甘肃省特色地理标志农产品，在兰州市永登县及周边种植历史悠久，目前已形成从种植、加工到销售的完整产业链。但长期以来，由于缺乏统一的质量评价标准，产品品质无法直观判定，消费者难以分辨优劣，出口也受到技术性贸易壁垒限制。好产品走不远、卖不上高价。　　为破解这一瓶颈，兰州海关技术中心把目光投向了标准体系建设。

五 | 该中心牵头起草的苦水玫瑰精油国家标准，对产品感官指标、理化参数、特征成分及检测方法作出统一规定，为玫瑰精油的生产、加工、贸易提供了明确的技术依据。

六 | 　　在此基础上，该中心又推动发布了苦水玫瑰精油国际标准，实现了甘肃省特色香料领域国际标准“零的突破”，出口贸易有了统一的技术语言，国际市场准入障碍也随之降低。

七 | 　　“以前客户看样品凭感觉，现在大家按同一个标准说话，品质好不好，数据说了算。”把存礼说，标准体系的建立，让苦水玫瑰精油有了统一的“身份标识”，也为企业拓展市场提供了权威背书。2025年11月底，在甘肃兰州一处商业街角，由高原苦水玫瑰制作的“西北特色花馍+咖啡”创新组合，日渐成为年轻人在冬日里的味蕾新宠。(资料图)李亚龙 摄　　标准只是第一步。围绕苦水玫瑰产业发展中的技术瓶颈，兰州海关技术中心联合甘肃省内龙头企业持续开展科研攻关，针对企业反映玫瑰花水品质难以稳定的痛点，优化设备运行参数与蒸馏萃取时间，从生产源头稳定了玫瑰花水产品品质，赋能企业增收，产品销量同比增长23.4%。　　“下一步，我们将继续围绕苦水玫瑰全产业链深化科研与服务，推动标准落地应用，助力甘肃苦水玫瑰品牌走得更远。”兰州海关技术中心高级工程师雷春妮说。　　从没有标准到国家标准出台，再到国际标准发布，兰州海关技术中心用一项标准、一套体系、一支队伍，帮助苦水玫瑰走出“优质不优价”的困局。

八 |

Current article:http://l2d.xiaqingzhuangdaminnan.cyou/today/index.html

Published on:00:17:38